We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

QuidelOrtho

Develops, manufactures and markets rapid diagnostic tests that focus on infectious diseases, reproductive health, and... read more Featured Products: More products

Download Mobile App




XT MicroSlide Assays Evaluated for Performance

By LabMedica International staff writers
Posted on 22 Jun 2022

One of the challenges clinical laboratories face when servicing pediatric centers is adequate specimen collection from infants and children in addition to performing multiple tests on the limited sample volume. More...

This challenge is significantly heightened in critically ill patients and in patients for whom phlebotomy is challenging. Diagnostic phlebotomy is a known cause of iatrogenic blood loss which can result in the aggravation of hospital-acquired anemia.

Clinical Biochemists at the Baylor College of Medicine (Houston, TX, USA) and their colleagues evaluated the analytical performance of the Vitros XT MicroSlide assay pairs on the Vitros XT 7600 (Ortho Clinical Diagnostics, Raritan NJ, USA) compared to single MicroSlides. Performance characteristics included within-run precision, analytical measurable range, method comparison, and interference verification.

The investigators compared six XT MicroSlide pairs on the Vitros XT 7600 with twelve corresponding single slide assays on the Vitros 5600 system. Currently available Vitros XT MicroSlide pairs include Alanine Aminotransferase/Aspartate Aminotransferase [ALTV-AST], Triglyceride/Cholesterol [TRIG-CHOL], Albumin/Total Protein [ALB-TP], Urea/Creatinine [UREA-CREA], Glucose/Calcium [GLU-CA], Total Bilirubin/Alkaline Phosphatase [TBIL-ALKP].

The scientists reported that the XT MicroSlides on Vitros XT 7600 demonstrated excellent precision, equivalent analytical measurable range, and strong method correlation with single slide assays on Vitros 5600 for most of the assays tested. Within-run CVs of the analytes ranged between 0.32% and 2.93% with between-run CV of less than 8.8% and linearity for all analytes was within the manufacturer's specified range. Interference studies showed comparable effects of hemolysis, lipemia, and bilirubin on both instruments. The total turnaround time (TAT), the XT7600 had a TAT of 31 minutes and 2 seconds compared to 69 minutes 2 seconds on the 5600. Similarly, the volume of samples utilized by the XT7600 was 53% less than the volume required by the 5600.

The authors concluded that the XT MicroSlide assays on the XT 7600 demonstrated comparable analytical measurement ranges, precision, and strong method correlation with the Single MicroSlides for all the assays. It is suitable for use in the pediatric setting as it accommodates lower sample volumes and improved turnaround times without any effect on performance. The study was published in the August 1, 2022 issue of the journal Practical Laboratory Medicine.

Related Links:
Baylor College of Medicine 
Ortho Clinical Diagnostics 


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.